Notice 14 Jul 2025 compliance, healthcare, regulations, dea, florida, pharmacy

💊Revocation of DEA Registration for JYA LLC - Major Implications

The Department of Justice has revoked the DEA registration of JYA LLC d/b/a Webb's Square Pharmacy due to serious violations, including dispensing controlled substances without legitimate prescriptions. The agency determined that these actions posed an imminent danger to public health, resulting in immediate sanctions and the denial of future registration applications. The ruling underscores the critical importance of compliance in pharmacy practice.

Learn More
Notice 14 Jul 2025 compliance, pennsylvania, registration, dea, controlled substances, pharmacy, public safety

💊DEA Revokes Pharmacy Registration Due to Compliance Failures

The DEA issued an Order to Show Cause and revoked the registration of Just Here II Pharmacy, citing failures to maintain accurate records for dispensing controlled substances, which poses an imminent danger to public health. The decision emphasizes the importance of compliance with federal and state regulations governing the pharmaceutical industry.

Learn More
Notice 16 Apr 2025 compliance, regulatory, pennsylvania, controlled substances, drug enforcement, pharmacy

💊DEA Revokes Registration of Empire and Skyline Pharmacies for Violations

The Drug Enforcement Administration issued an Order to Show Cause and Immediate Suspension of Registrations to Empire Pharmacy Inc. and Skyline Pharmacy Inc. for alleged violations concerning recordkeeping and dispensing of controlled substances. The order indicates potential revocation of their registration, deeming their operations inconsistent with public safety and legal standards.

Learn More
Notice 14 Apr 2025 compliance, regulation, texas, dea, controlled substances, pharmacy

💊DEA Revocation of Mariste Pharmacy's Registration - Overview

The Drug Enforcement Administration (DEA) has issued a decision revoking Mariste Pharmacy's registration due to significant violations related to controlled substances. Allegations include failure to address red flags of abuse in prescriptions and inadequate record-keeping, raising concerns for regulatory compliance and public health. The decision emphasizes the importance of adherence to laws governing drug dispensing and security.

Learn More
Notice 1 Apr 2025 compliance, regulation, texas, controlled substances, drug enforcement, pharmacy

🚫Analysis of Baijes Bissonnet Pharmacy DEA Registration Denial

The Drug Enforcement Administration issued a denial notice to Baijes Bissonnet Pharmacy, highlighting significant compliance failures related to controlled substances. The notice outlines allegations of neglecting red flags indicating prescription abuse and diversion, leading to substantial legal risks and regulatory consequences for the pharmacy.

Learn More
Compliance, Regulatory 23 Jan 2025 compliance, dea, controlled substances, florida, registration revocation, drug enforcement administration, pharmacy
Regulatory Compliance, Business Operations 23 Jan 2025 compliance, regulation, louisiana, drug enforcement, pharmacy